Patents by Inventor Liubin GUO

Liubin GUO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLP-1 Receptor Agonist and Composition and Use Thereof
    Publication number: 20240360110
    Abstract: Provided are a GLP-1 receptor agonist compound and a composition and use thereof. The compound can be used for treating or preventing GLP-1 receptor-mediated diseases or disorders and related diseases or disorders.
    Type: Application
    Filed: March 22, 2024
    Publication date: October 31, 2024
    Inventors: Wenqiang Zhai, Zhimin Zhang, Zhe Wang, Hao Pan, Liubin Guo, Qian Wang
  • THIOPHENE GLP-1 RECEPTOR AGONIST AND USE THEREOF
    Publication number: 20240208952
    Abstract: Provided are a series of thiophene GLP-I receptor agonist com-pounds, a preparation method therefor and the pharmaceutical use thereof. The compounds can be used for preparing drugs for treating or preventing GLP-1-mediated diseases and related diseases.
    Type: Application
    Filed: March 17, 2022
    Publication date: June 27, 2024
    Inventors: Wenqiang ZHAI, Zhimin ZHANG, Liubin GUO, Dongzhou LIU, Hao PAN
  • GLP-1 receptor agonist and composition and use thereof
    Patent number: 11981666
    Abstract: Provided are a GLP-1 receptor agonist compound and a composition and use thereof. The compound can be used for treating or preventing GLP-1 receptor-mediated diseases or disorders and related diseases or disorders.
    Type: Grant
    Filed: September 13, 2023
    Date of Patent: May 14, 2024
    Assignee: HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD.
    Inventors: Wenqiang Zhai, Zhimin Zhang, Zhe Wang, Hao Pan, Liubin Guo, Qian Wang
  • GLP-1 Receptor Agonist and Composition and Use Thereof
    Publication number: 20240116906
    Abstract: Provided are a GLP-1 receptor agonist compound and a composition and use thereof. The compound can be used for treating or preventing GLP-1 receptor-mediated diseases or disorders and related diseases or disorders.
    Type: Application
    Filed: September 13, 2023
    Publication date: April 11, 2024
    Inventors: Wenqiang ZHAI, Zhimin ZHANG, Zhe WANG, Hao PAN, Liubin GUO, Qian WANG